Ensysce Biosciences (ENSC) Other Operating Expenses (2018 - 2020)

Ensysce Biosciences (ENSC) has reported Other Operating Expenses for 3 consecutive years, with $230000.0 the latest figure, recorded in Q2 2020.

• In Q2 2020, Other Operating Expenses fell 63.26% year-over-year to $230000.0; the TTM figure through Mar 2021 stood at $230000.0 (down 92.65% YoY), while the FY2020 annual figure was $220000.0, down 93.39% from the prior year.
• Other Operating Expenses advanced to $230000.0 in Q2 2020 per ENSC's latest filing, from -$10000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.9 million in Q4 2019 and bottomed at -$10000.0 in Q1 2020.
• Historically, Other Operating Expenses has averaged $514483.4 across 3 years, with a median of $311538.0 in 2018.
• Annual changes were most pronounced in 2019 — Other Operating Expenses jumped 100.92% — and 2020, when it sank 105.29%.
• Ensysce Biosciences' Other Operating Expenses stood at $600005.0 in 2018, then jumped by 221.52% to $1.9 million in 2019, then plunged by 88.08% to $230000.0 in 2020.
• Business Quant data shows ENSC's Other Operating Expenses at $230000.0 in Q2 2020, -$10000.0 in Q1 2020, and $1.9 million in Q4 2019.